Articleresearch

5:2 Intermittent Fasting Reduces Liver Fat, ALT, and Inflammation in NAFLD: What the Research Shows

A 12-week RCT in 44 NAFLD patients found 5:2 fasting cut liver steatosis (CAP −23 dB/m), ALT by 31%, and triglycerides by 25% vs control. Frontiers in Nutrition, 2022.

FastingInPractice Editors

5:2 Intermittent Fasting Reduces Liver Fat, ALT, and Inflammation in NAFLD: What the Research Shows

Medical disclaimer: This article summarises published research for informational purposes only. It is not medical advice and is not a substitute for guidance from a qualified health professional. Always consult your doctor before starting any fasting protocol, especially if you have an existing health condition or take medication.

Study at a Glance

TitleEffects of the 5:2 intermittent fasting diet on non-alcoholic fatty liver disease: A randomized controlled trial
JournalFrontiers in Nutrition
PublishedJuly 2022
Study typeRandomized controlled trial
Total participants44
Duration12 weeks
Lead researcherHamed Kord Varkaneh
InstitutionDepartment of Clinical Nutrition and Dietetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran
FundingNot reported
SourceView on PubMed →

What This Study Looked At

Researchers wanted to know whether the 5:2 intermittent fasting protocol — 5 days of normal eating combined with 2 consecutive very-low-calorie fasting days per week — could meaningfully improve liver health in people already diagnosed with non-alcoholic fatty liver disease (NAFLD). NAFLD affects roughly one in four adults globally and is closely tied to insulin resistance, excess body fat, and metabolic dysfunction. Existing standard care relies heavily on lifestyle change, but adherence to daily calorie restriction is notoriously poor. The team tested whether structured intermittent fasting could produce measurable improvements in liver fat, liver enzymes, and inflammatory markers compared to continuing with a usual diet. Internal links to related research: see Can intermittent fasting reverse fatty liver? and the full 5:2 intermittent fasting explainer.


Who Was Studied

GroupParticipantsWhat They Did
5:2 Intermittent Fasting21 people5 days of normal food intake each week; 2 consecutive fasting days (~500–600 kcal)
Control23 peopleContinued their usual diet with no structured fasting protocol

Participant profile: Overweight and obese adults (mean BMI ~30.4 kg/m²) with confirmed NAFLD, recruited from a university medical centre in Tehran, Iran. Mean baseline weight approximately 86.7 kg.

How 5:2 fasting worked in this study: For two consecutive days each week, participants consumed a very low-calorie intake (approximately 500–600 kcal). On the remaining five days, they ate normally without calorie restriction. This cycle was repeated for 12 consecutive weeks.


What the Researchers Found

Liver Fat and Fibrosis

Measure5:2 IF Group (Baseline → Week 12)Change
Liver steatosis — CAP score313.09 → 289.95 dB/m−23.14 dB/m
Liver fibrosis6.97 → 5.58 kPa−1.39 kPa

The CAP (Controlled Attenuation Parameter) score is a non-invasive ultrasound measure of liver fat — higher scores mean more fat in the liver. A reduction of more than 23 dB/m over 12 weeks represents a clinically meaningful improvement in liver steatosis grade. Liver fibrosis (measured by transient elastography) also decreased significantly.

Liver Enzymes

EnzymeBaselineWeek 12Change
ALT41.42 U/L28.38 U/L−31.4%
AST34.19 U/L25.95 U/L−24.1%

Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are the primary blood markers of liver inflammation and damage. Both dropped significantly in the IF group compared to the control group. ALT normalised (below 40 U/L) in the IF group by week 12.

Body Composition and Weight

MeasureBaselineWeek 12Change
Body weight86.65 kg82.94 kg−3.71 kg
BMI30.42 kg/m²29.13 kg/m²−1.29 kg/m²
Waist circumference103.52 cm100.52 cm−3.00 cm
Fat mass26.64 kg23.85 kg−2.79 kg

Metabolic and Inflammatory Markers

MarkerBaselineWeek 12Change
Triglycerides171.23 mg/dL128.04 mg/dL−25.2%
hsCRP (inflammation)2.95 mg/L2.40 mg/L−18.6%
CK-18 (liver cell death marker)1.32 ng/mL1.19 ng/mL−9.8%

Triglycerides dropping by more than 25% is a significant finding — elevated triglycerides are both a cause and consequence of NAFLD, and their reduction indicates an improvement in the underlying metabolic dysfunction. CK-18 (cytokeratin-18) is a circulating marker of hepatocyte apoptosis (liver cell death) and its reduction suggests less ongoing liver injury.

What Did Not Change

  • Lean mass was not significantly affected, suggesting the weight lost was predominantly fat
  • LDL cholesterol showed no significant change in this study
  • HDL cholesterol change was not reported as statistically significant

What the Researchers Concluded

The authors concluded that adhering to a 5:2 intermittent fasting diet for 12 weeks can meaningfully reduce body weight, fat mass, and anthropometric markers of obesity — and also produce significant improvements in liver steatosis, liver enzymes, triglycerides, and inflammatory biomarkers in patients with NAFLD. They described 5:2 IF as a viable dietary strategy for NAFLD management.


What This Means If You Fast

  • Liver fat responds to fasting in 12 weeks. The steatosis reduction (−23 dB/m CAP score) is not subtle — it's a grade of improvement that would show up as a meaningful change on liver imaging.
  • Liver enzymes can normalise. ALT dropped from a mildly elevated 41 U/L to a normal 28 U/L — the kind of change that gets noticed at a GP appointment. If your liver health is a concern, structured IF may be one of the most direct dietary tools available.
  • Two fasting days per week is enough. The 5:2 protocol is far from the most aggressive fasting approach — only 2 days per week required significant dietary restriction. For people who struggle with daily calorie counting, this shows a different path to meaningful metabolic change.
  • Inflammation came down too. The hsCRP reduction (−18.6%) adds to a growing body of evidence that fasting reduces systemic inflammation, not just liver-specific markers.
  • Weight loss was modest but targeted. Nearly all of the 3.7 kg lost was fat (2.79 kg fat mass reduction), not muscle — an important finding for people concerned about lean mass preservation during fasting.
  • Triglycerides fell sharply. A 25% drop in 12 weeks is a meaningful cardiovascular benefit layered on top of the liver improvement — NAFLD patients typically have elevated triglycerides as part of their metabolic profile.

Study Limitations

  • Small sample size. With 21 participants in the IF group and 23 in the control group, results need replication in larger trials before drawing firm conclusions
  • Single centre. Conducted at one Iranian university hospital — the population may not generalise across ethnicities, dietary backgrounds, or healthcare settings
  • No liver biopsy. While transient elastography and CAP are validated non-invasive tools, histological confirmation (liver biopsy) remains the gold standard for NAFLD staging
  • No long-term follow-up. 12 weeks is short — whether improvements are maintained at 6 or 12 months is unknown
  • Self-reported dietary intake. The “normal eating” days in the IF group relied on self-reporting, which may underestimate food consumed or overestimate adherence
  • Funding and conflicts of interest: Not reported in the available abstract

Source

Kord Varkaneh H, Salehi Sahlabadi A, Găman MA, Rajabnia M, Macit-Çelebi MS, Santos HO, Hekmatdoost A. (2022). Effects of the 5:2 intermittent fasting diet on non-alcoholic fatty liver disease: A randomized controlled trial. Frontiers in Nutrition, 9, 948655. PMID: 35958257


Frequently Asked Questions

How quickly does intermittent fasting improve fatty liver?

This study showed significant improvements in liver fat (CAP score), liver enzymes, and triglycerides within 12 weeks of following the 5:2 fasting protocol. Other studies have shown measurable changes in as little as 8 weeks with daily time-restricted eating approaches.

Does the 5:2 diet work better than daily calorie restriction for NAFLD?

This study compared 5:2 IF to a usual diet (not a daily calorie-restricted diet), so it can't answer that direct comparison. Separately, research on general weight loss suggests IF and daily calorie restriction produce similar weight outcomes, but some patients find IF easier to maintain long-term.

Can fasting reverse NAFLD completely?

The evidence shows fasting can reduce liver fat and improve liver enzyme levels meaningfully. Whether this constitutes "reversal" depends on the starting severity of NAFLD. Mild-to-moderate NAFLD (fatty liver without significant fibrosis) is most likely to respond well to lifestyle interventions including fasting. Advanced fibrosis requires medical management alongside any dietary change.

Is 5:2 fasting safe if you have NAFLD?

The study found the protocol safe over 12 weeks in overweight adults with confirmed NAFLD, with no adverse events reported in the summary findings. However, anyone with liver disease should consult a hepatologist or gastroenterologist before starting a fasting protocol — NAFLD exists on a spectrum and some stages require closer monitoring.

Why does intermittent fasting improve liver fat?

Several mechanisms are likely involved: fasting reduces liver fat by lowering insulin (which signals the liver to store fat), promoting fat oxidation (burning of triglycerides for energy), reducing de novo lipogenesis (new fat production), and activating autophagy in liver cells. The 5:2 protocol creates two significant metabolic reset periods per week that cumulatively shift the liver's fat balance.


Related Research and Articles


Want the complete guide to fasting? Get Intermittent Fasting in Practice on Amazon — and claim 3 months free on our fasting app at fastinginpractice.com/redeem.

📗

Want the complete guide?

Intermittent Fasting in Practice

Everything in this article — and hundreds more pages of practical guidance, protocols, recipes, and mindset strategies — is covered in depth in the book, available now on Amazon.

💬

Have personal experience with this? Your story helps thousands of people.